SZS

Shaare Zedek Medical Center and Arieli Capital Announce the Establishment of the Shaare Zedek Arieli Innovation Hub - SHAAR

Retrieved on: 
Tuesday, December 19, 2023
JDA, SZMC, Entrepreneurship, Partnership, Physician, Research, SZS, Shaare Zedek Medical Center, Innovation Hub, Environment, Management

JERUSALEM and NEW YORK, Dec. 19, 2023 /PRNewswire/ -- Shaare Zedek Medical Center (SZMC), Jerusalem's largest multi-disciplinary medical center, and Arieli Capital, LLC (Arieli), a global multifaceted investment firm, today announced the creation of the Shaare Zedek Arieli Innovation Hub, SHAAR. This landmark center is set to become a cornerstone hub for healthcare innovation.

Key Points: 
  • Healthcare Innovation Hub to focus on transformative startups, advancing innovative technologies and supporting pioneering research and development that will benefit humanity
    JERUSALEM and NEW YORK, Dec. 19, 2023 /PRNewswire/ -- Shaare Zedek Medical Center (SZMC), Jerusalem's largest multi-disciplinary medical center, and Arieli Capital, LLC (Arieli), a global multifaceted investment firm, today announced the creation of the Shaare Zedek Arieli Innovation Hub, SHAAR.
  • Shaare Zedek Scientific (SZS), the research and innovation arm of SZMC, and Arieli are leading the new SHAAR Hub, which was launched with support from the Jerusalem Development Authority (JDA).
  • SHAAR, located within the Shaare Zedek Medical Center, combines SZMC's medical expertise and world-class facilities with Arieli's investment experience and track record of fostering innovation and growth platforms.
  • "We are honored to partner with the Shaare Zedek Medical Center to bring the important mission of SHAAR to life," said Evan Renov, Co-Founder and Chief Executive Officer of Arieli.

ZOZEN Boiler Energizes Uzbekistan Chemical Industry

Retrieved on: 
Friday, August 27, 2021
Other Energy, Utilities, Oil, Gas, Other Manufacturing, Energy, Steel, Engineering, Manufacturing, SZS, World, Method, Efficiency, Natural gas, Safety, AO, Fracture, Heating, ventilation, and air conditioning

Previously, a set of SZS series gas-fired steam boiler provided by ZOZEN Boiler to AO NAVOIYAZOT, a large chemical enterprise in Uzbekistan, has been running smoothly for about one year.

Key Points: 
  • Previously, a set of SZS series gas-fired steam boiler provided by ZOZEN Boiler to AO NAVOIYAZOT, a large chemical enterprise in Uzbekistan, has been running smoothly for about one year.
  • In the production process of ZOZEN Boiler, every detail condenses the quality and ingenuity of ZOZEN people, and this is also an important guarantee for ZOZEN Boiler to go to the World.
  • ZOZEN Boiler has become one of the trustworthy industrial boiler brands.
  • At the same time, ZOZEN Boiler also focuses on training the technical team that specializes in serving Russian-speaking countries and regions to provide a complete set of boiler solutions.

GCANRx Signs Licensing Agreement with Shaare Zedek Scientific for Innovative Neuropsychiatric Cannabinoid Therapy

Retrieved on: 
Thursday, August 19, 2021
Neurology, Research, Autism, Securities Act of 1933, Safety, Risk, Partnership, Medicine, OTCQB, Securities Exchange Act of 1934, SZMC, Therapy, U.S. Securities and Exchange Commission, Nature, Communication, SZS, Technology, Industry, Shaare Zedek Medical Center, Bed, Lists of diseases, Drug Quality and Security Act, Hope, Cannabidiol, ASD, Pediatric Neurology, Development, Cannabis, Publication, Security (finance), Company, Private Securities Litigation Reform Act, GLOBE, Anxiety, Physician, Schizophrenia, Uncertainty, Patient, Annual report, Behavioral Problems, Parent, Pharmaceutical industry

The agreement covers the license of SZSs novel cannabinoid therapeutic focused on treatment of autism, schizophrenia, Parkinsons disease, Alzheimers disease and other neuropsychiatric disorders.

Key Points: 
  • The agreement covers the license of SZSs novel cannabinoid therapeutic focused on treatment of autism, schizophrenia, Parkinsons disease, Alzheimers disease and other neuropsychiatric disorders.
  • Accompanying the license agreement is a joint research and development agreement, which will focus on continuing the clinical program spearheaded by Dr. Adi Aran, M.D.
  • Director of Pediatric Neurology at SZMC, Board Member of the Israeli Society for Pediatric Neurology, and co-inventor of the novel cannabinoid therapy.
  • The results provided very compelling evidence that medical cannabis is an effective therapy for children on the autism spectrum.